1. Home
  2. SNTI vs JL Comparison

SNTI vs JL Comparison

Compare SNTI & JL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNTI
  • JL
  • Stock Information
  • Founded
  • SNTI 2016
  • JL 1985
  • Country
  • SNTI United States
  • JL Hong Kong
  • Employees
  • SNTI N/A
  • JL N/A
  • Industry
  • SNTI Biotechnology: Pharmaceutical Preparations
  • JL
  • Sector
  • SNTI Health Care
  • JL
  • Exchange
  • SNTI Nasdaq
  • JL NYSE
  • Market Cap
  • SNTI 14.1M
  • JL 13.7M
  • IPO Year
  • SNTI N/A
  • JL 2024
  • Fundamental
  • Price
  • SNTI $2.19
  • JL $0.39
  • Analyst Decision
  • SNTI
  • JL
  • Analyst Count
  • SNTI 0
  • JL 0
  • Target Price
  • SNTI N/A
  • JL N/A
  • AVG Volume (30 Days)
  • SNTI 24.1K
  • JL 303.0K
  • Earning Date
  • SNTI 11-11-2024
  • JL 11-02-2024
  • Dividend Yield
  • SNTI N/A
  • JL N/A
  • EPS Growth
  • SNTI N/A
  • JL N/A
  • EPS
  • SNTI N/A
  • JL 0.03
  • Revenue
  • SNTI $338,000.00
  • JL $28,378,669.00
  • Revenue This Year
  • SNTI $254.47
  • JL N/A
  • Revenue Next Year
  • SNTI $169.66
  • JL N/A
  • P/E Ratio
  • SNTI N/A
  • JL $15.04
  • Revenue Growth
  • SNTI N/A
  • JL N/A
  • 52 Week Low
  • SNTI $1.52
  • JL $0.30
  • 52 Week High
  • SNTI $8.48
  • JL $29.95
  • Technical
  • Relative Strength Index (RSI)
  • SNTI 39.08
  • JL 49.58
  • Support Level
  • SNTI $2.08
  • JL $0.36
  • Resistance Level
  • SNTI $2.56
  • JL $0.44
  • Average True Range (ATR)
  • SNTI 0.24
  • JL 0.03
  • MACD
  • SNTI -0.04
  • JL -0.00
  • Stochastic Oscillator
  • SNTI 10.57
  • JL 40.82

About SNTI Senti Biosciences Inc.

Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.

About JL J-LONG GROUP LIMITED

J-Long Group Ltd is an established distributor in Hong Kong of reflective and non-reflective garment trims including, among others, heat transfers, fabrics, woven labels and tapes, sewing badges, piping, zipper pullers and drawcords. It also offers a wide range of apparel solution services to cater to its customers' needs for reflective and non-reflective garment trims, ranging from market trend analysis, product design and development and production to quality control.

Share on Social Networks: